vs
阿普塔集团（ATR）与Liberty Energy Inc.（LBRT）财务数据对比。点击上方公司名可切换其他公司
Liberty Energy Inc.的季度营收约是阿普塔集团的1.1倍（$1.0B vs $962.7M），阿普塔集团净利率更高（7.7% vs 2.2%，领先5.5%），阿普塔集团同比增速更快（13.5% vs 4.5%），过去两年阿普塔集团的营收复合增速更高（2.6% vs -6.2%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Liberty Energy Inc.是北美领先的能源服务供应商，专注为油气运营企业提供水力压裂及完井解决方案，服务覆盖美国主要页岩产区，供应低排放作业设备及定制化支持，帮助提升油气井生产效率。
ATR vs LBRT — 直观对比
营收规模更大
LBRT
是对方的1.1倍
$962.7M
营收增速更快
ATR
高出9.0%
4.5%
净利率更高
ATR
高出5.5%
2.2%
两年增速更快
ATR
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.0B |
| 净利润 | $74.3M | $22.6M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | 2.2% |
| 净利率 | 7.7% | 2.2% |
| 营收同比 | 13.5% | 4.5% |
| 净利润同比 | -26.4% | 64.8% |
| 每股收益（稀释后） | $1.13 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRLBRT
| Q1 26 | — | $1.0B | ||
| Q4 25 | $962.7M | $1.0B | ||
| Q3 25 | $961.1M | $947.4M | ||
| Q2 25 | $966.0M | $1.0B | ||
| Q1 25 | $887.3M | $977.5M | ||
| Q4 24 | $848.1M | $943.6M | ||
| Q3 24 | $909.3M | $1.1B | ||
| Q2 24 | $910.1M | $1.2B |
净利润ATRLBRT
| Q1 26 | — | $22.6M | ||
| Q4 25 | $74.3M | $13.7M | ||
| Q3 25 | $127.9M | $43.1M | ||
| Q2 25 | $111.7M | $71.0M | ||
| Q1 25 | $78.8M | $20.1M | ||
| Q4 24 | $100.9M | $51.9M | ||
| Q3 24 | $100.0M | $73.8M | ||
| Q2 24 | $90.5M | $108.4M |
毛利率ATRLBRT
| Q1 26 | — | — | ||
| Q4 25 | — | 20.6% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | 22.1% | ||
| Q1 25 | — | 22.1% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 27.9% |
营业利润率ATRLBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | 11.0% | 1.9% | ||
| Q3 25 | 14.2% | -0.3% | ||
| Q2 25 | 14.9% | 3.6% | ||
| Q1 25 | 12.8% | 1.9% | ||
| Q4 24 | 14.2% | 2.6% | ||
| Q3 24 | 15.2% | 9.4% | ||
| Q2 24 | 13.8% | 12.2% |
净利率ATRLBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | 7.7% | 1.3% | ||
| Q3 25 | 13.3% | 4.5% | ||
| Q2 25 | 11.6% | 6.8% | ||
| Q1 25 | 8.9% | 2.1% | ||
| Q4 24 | 11.9% | 5.5% | ||
| Q3 24 | 11.0% | 6.5% | ||
| Q2 24 | 9.9% | 9.3% |
每股收益（稀释后）ATRLBRT
| Q1 26 | — | $0.14 | ||
| Q4 25 | $1.13 | $0.08 | ||
| Q3 25 | $1.92 | $0.26 | ||
| Q2 25 | $1.67 | $0.43 | ||
| Q1 25 | $1.17 | $0.12 | ||
| Q4 24 | $1.48 | $0.31 | ||
| Q3 24 | $1.48 | $0.44 | ||
| Q2 24 | $1.34 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $699.1M |
| 总债务越低越好 | $1.1B | $7.1M |
| 股东权益账面价值 | $2.7B | $1.9B |
| 总资产 | $5.3B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ATRLBRT
| Q1 26 | — | $699.1M | ||
| Q4 25 | $409.5M | $27.6M | ||
| Q3 25 | $264.8M | $13.5M | ||
| Q2 25 | $169.8M | $19.6M | ||
| Q1 25 | $136.8M | $24.1M | ||
| Q4 24 | $226.2M | $20.0M | ||
| Q3 24 | $327.9M | $23.0M | ||
| Q2 24 | $223.9M | $30.0M |
总债务ATRLBRT
| Q1 26 | — | $7.1M | ||
| Q4 25 | $1.1B | $246.6M | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | $190.5M | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
股东权益ATRLBRT
| Q1 26 | — | $1.9B | ||
| Q4 25 | $2.7B | $2.1B | ||
| Q3 25 | $2.8B | $2.1B | ||
| Q2 25 | $2.7B | $2.0B | ||
| Q1 25 | $2.5B | $2.0B | ||
| Q4 24 | $2.5B | $2.0B | ||
| Q3 24 | $2.5B | $2.0B | ||
| Q2 24 | $2.4B | $1.9B |
总资产ATRLBRT
| Q1 26 | — | $4.4B | ||
| Q4 25 | $5.3B | $3.6B | ||
| Q3 25 | $5.1B | $3.5B | ||
| Q2 25 | $4.9B | $3.4B | ||
| Q1 25 | $4.5B | $3.4B | ||
| Q4 24 | $4.4B | $3.3B | ||
| Q3 24 | $4.6B | $3.3B | ||
| Q2 24 | $4.5B | $3.2B |
负债/权益比ATRLBRT
| Q1 26 | — | 0.00× | ||
| Q4 25 | 0.43× | 0.12× | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | 0.10× | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | — |
| 自由现金流经营现金流 - 资本支出 | $96.9M | — |
| 自由现金流率自由现金流/营收 | 10.1% | — |
| 资本支出强度资本支出/营收 | 9.0% | 13.1% |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRLBRT
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | $195.4M | ||
| Q3 25 | $177.6M | $51.5M | ||
| Q2 25 | $126.0M | $170.6M | ||
| Q1 25 | $82.7M | $192.1M | ||
| Q4 24 | $178.2M | $177.3M | ||
| Q3 24 | $229.3M | $244.5M | ||
| Q2 24 | $143.6M | $248.2M |
自由现金流ATRLBRT
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | $-10.0M | ||
| Q3 25 | $114.3M | $-67.2M | ||
| Q2 25 | $62.5M | $33.1M | ||
| Q1 25 | $25.9M | $58.2M | ||
| Q4 24 | $112.2M | $-26.2M | ||
| Q3 24 | $162.7M | $77.9M | ||
| Q2 24 | $75.4M | $112.2M |
自由现金流率ATRLBRT
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | -1.0% | ||
| Q3 25 | 11.9% | -7.1% | ||
| Q2 25 | 6.5% | 3.2% | ||
| Q1 25 | 2.9% | 6.0% | ||
| Q4 24 | 13.2% | -2.8% | ||
| Q3 24 | 17.9% | 6.8% | ||
| Q2 24 | 8.3% | 9.7% |
资本支出强度ATRLBRT
| Q1 26 | — | 13.1% | ||
| Q4 25 | 9.0% | 19.8% | ||
| Q3 25 | 6.6% | 12.5% | ||
| Q2 25 | 6.6% | 13.2% | ||
| Q1 25 | 6.4% | 13.7% | ||
| Q4 24 | 7.8% | 21.6% | ||
| Q3 24 | 7.3% | 14.6% | ||
| Q2 24 | 7.5% | 11.7% |
现金转化率ATRLBRT
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | 14.28× | ||
| Q3 25 | 1.39× | 1.20× | ||
| Q2 25 | 1.13× | 2.40× | ||
| Q1 25 | 1.05× | 9.55× | ||
| Q4 24 | 1.77× | 3.42× | ||
| Q3 24 | 2.29× | 3.31× | ||
| Q2 24 | 1.59× | 2.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
LBRT
暂无分部数据
